Liquid clues: tracking early-stage breast cancer with ctDNA - a mini review
{{output}}
Circulating tumor DNA (ctDNA) is a testing modality that has several potential applications in the management of non-metastatic breast cancer. In this mini review, we discuss its role in early detection, treatment response assessment, and surveillance for mini... ...
